CTLA4 and neoplasm: The first anti-CTLA-4 2F’-RNA aptamer was reported by Gilboa’s group and they showed that this aptamer could bind CTLA-4 specifically and inhibit CTLA-4 function in vitro and enhance tumor immunity in mice [19].